— Multi-product collaboration will address pathogens for which the World Health Organization (WHO) has declared there is a “critical need” for new drugs due to carbapenem-resistance in Acinetobacter, Pseudomonas aeruginosa, and Enterobacteriaceae (CRE… […]
Agreement Leverages Prometheus Biosciences’ Proprietary Bioinformatics Analysis Platform, Companion Diagnostics to Speed Development and Discovery
SAN DIEGO, Oct. 3, 2019 /PRNewswire/ — Prometheus Biosciences, Inc., a biopharmaceutical company commi… […]
Company expands pipeline of innovative therapies for immunocompromised patients
SAN DIEGO, Sept. 16, 2019 /PRNewswire/ — Amplyx Pharmaceuticals, a biotech company dedicated to developing innovative therapies for debilitating and life-threatening dis… […]
SAN DIEGO, Aug. 28, 2019 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced Jerome Bettis, NF… […]
– GSK exercises option to license program following positive Phase 2 results- Transaction provides Ionis with significant participation in the commercial success of HBV program
CARLSBAD, Calif., Aug. 27, 2019 /PRNewswire/ — Ionis Pharmaceuticals, In… […]
SAN DIEGO and SAN JOSE, Calif., Aug. 14, 2019 /PRNewswire/ — MiLaboratories LLC, a technology leader in T-cell receptor (TCR) and B-cell receptor (BCR) profiling and MIODx, a well-known immunosequencing specialist, announced today a collaboration a… […]
SAN DIEGO, Aug. 1, 2019 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first publicly traded cannabis company in the United States that launched the world’s preeminent cannabis-derived nutraceutical products, brands and su… […]
SAN DIEGO, July 9, 2019 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced a clinical collaboration agreement with Novartis to evaluate the combination of MRTX849, Mirati’s investiga… […]
Development Collaboration Will Initially Focus on CAR T-Cell Therapy for Triple-Negative Breast Cancer
SAN DIEGO and PENNINGTON, N.J., June 27, 2019 /PRNewswire/ — OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing late-stage… […]
MINEOLA, N.Y. and SAN DIEGO, June 25, 2019 /PRNewswire/ — NYU Winthrop Hospital and Progenity, Inc., today announced a collaborative research and development initiative for women’s health with a focus on preterm births. As part of the init… […]
Copyright © 2019 San Diego Biotechnology Network (DBA of Comprendia. LLC)
